Premium
First Graphene Ltd (QB) (FGPHF)
USOTC
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2025-10-28 | Bergen Asset Management, LLCSociété | -5,40M | 295,63k | Vente | 0,05 | 74,84M | -6,73% |
| 2025-12-12 | Dr. Andrew GoodwinSenior Scientific Advisor & Non Executive Director | 500,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-04 | Mr. Michael James QuinertNon-Executive Director | 500,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-04 | Mr. Michael BellMD, CEO & Director | 2,00M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-09-09 | Bergen Asset Management, LLCSociété | -8,47M | 445,42k | Vente | 0,05 | 80,24M | -9,55% |
| 2025-09-22 | Mr. Michael James QuinertNon-Executive Director | 50,00k | 0,00 | Derivative Exercise and Retained Stock | - | 442,50k | 12,74% |
| 2025-09-22 | Dr. Andrew GoodwinSenior Scientific Advisor & Non Executive Director | 39,32k | 0,00 | Derivative Exercise and Retained Stock | - | 1,90M | 2,11% |
| 2025-09-22 | Gregorach Pty LtdSociété | 419,07k | 0,00 | Derivative Exercise and Retained Stock | - | 15,69M | 2,74% |
| 2025-09-22 | Mr. Michael BellMD, CEO & Director | 1,57M | 0,00 | Derivative Exercise and Retained Stock | - | 5,39M | 41,00% |
| 2025-09-22 | Mr. Michael BellMD, CEO & Director | -1,57M | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-08-01 | Bergen Asset Management, LLCSociété | -5,74M | 182,69k | Vente | 0,03 | 88,71M | -6,07% |
| 2025-09-05 | Bergen Asset Management, LLCSociété | 34,87M | 0,00 | Achat | - | 88,71M | 64,75% |
| 2025-06-30 | Mr. Michael James QuinertNon-Executive Director | -21,63k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-06-30 | Mr. Michael BellMD, CEO & Director | -432,68k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-06-30 | Dr. Andrew GoodwinSenior Scientific Advisor & Non Executive Director | -21,63k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-06-30 | Mr. Warwick Robert GrigorNon-Executive Chairman | -43,27k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-08-29 | Mr. Warwick Robert GrigorNon-Executive Chairman | -43,27k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-01-17 | Bergen Asset Management, LLCSociété | 59,58M | 1,11M | Achat | 0,01 - 0,05 | 59,58M | - |
| 2025-07-01 | Dr. Andrew GoodwinSenior Scientific Advisor & Non Executive Director | -68,83k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-07-01 | Mr. Warwick Robert GrigorNon-Executive Chairman | -137,66k | 0,00 | Other Derivative Disposition | - | - | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
